Expression changes of genes associated with apoptosis and survival processes in Parkinson's disease

Neuroscience Letters

Volumn 615, Issue , 2016, Pages 72-77

  Yalçinkaya, Nazli ^a   Haytural, Hazal ^a   Bilgiç, Başar ^b   Özdemir, Özkan ^a   Hanağasi, Haşmet ^b   Küçükali, Cem Ismail ^a   Özbek, Zeynep ^c   Akcan, Uğur ^a   Idrisoğlu, Halil Atilla ^a   Gürvit, Hakan ^b   Tüzün, Erdem ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c Eyup State Hospital Neurosurgery Clinic   (Turkey)

Author keywords

Akt; Apoptosis; Disease; Parkinson's; Real time PCR; Survival

Indexed keywords

APOPTOSIS INDUCING FACTOR; CASPASE 3; CASPASE 9; DJ 1 PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL 2; PROTEIN KINASE B; ROTENONE; BIOLOGICAL MARKER; PTEN PROTEIN, MOUSE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST; OXIDATIVE STRESS; PARKINSON DISEASE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; AGED; ANIMAL; BRAIN; C57BL MOUSE; CASE CONTROL STUDY; GENETICS; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PATHOLOGY; SIGNAL TRANSDUCTION;

AGED; ANIMALS; APOPTOSIS; APOPTOSIS INDUCING FACTOR; BIOMARKERS; BRAIN; CASE-CONTROL STUDIES; CASPASE 3; CASPASE 9; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MICE, INBRED C57BL; MIDDLE AGED; PARKINSON DISEASE; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; PTEN PHOSPHOHYDROLASE; ROTENONE; SIGNAL TRANSDUCTION;

EID: 84956833646     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2016.01.029     Document Type: Article

References (27)

1. Dias V., Junn E., Mouradian M.M. The role of oxidative stress in Parkinson's disease. J. Parkinson's Dis. 2013, 3:461-491.
2. Cannon J.R., Greenamyre J.T. The role of environmental exposures in neurodegeneration and neurodegenerative diseases. Toxicol. Sci. 2011, 124:225-250.
3. Caudle W.M., Zhang J. Glutamate, excitotoxicity, and programmed cell death in Parkinson disease. Exp. Neurol. 2009, 220:230-233.
4. Chinta S.J., Andersen J.K. Redox imbalance in Parkinson's disease. Biochim. Biophys. Acta 2008, 1780:1362-1367.
5. Dauer W., Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003, 39:889-909.
6. Cheng C.M., Reinhardt R.R., Lee W.H., Joncas G., Patel S.C., Bondy C.A. Insulin-like growth factor 1 regulates developing brain glucose metabolism. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:10236-10241.
7. Kim R.H., Smith P.D., Aleyasin H., Hayley S., Mount M.P., Pownall S., Wakeham A., You-Ten A.J., Kalia S.K., Horne P., Westaway D., Lozano A.M., Anisman H., Park D.S., Mak T.W. Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:5215-5220.
8. Malagelada C., Jin Z.H., Greene L.A. RTP801 is induced in Parkinson's disease and mediates neuron death by inhibiting Akt phosphorylation/activation. J. Neurosci. 2008, 28:14363-14371.
9. Fallon L., Bélanger C.M., Corera A.T., Kontogiannea M., Regan-Klapisz E., Moreau F., Voortman J., Haber M., Rouleau G., Thorarinsdottir T., Brice A., van Bergen En Henegouwen P.M., Fon E.A. A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K-Akt signalling. Nat. Cell Biol. 2006, 8:834-842.
10. Coffer P.J., Jin J., Woodgett J.R. Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem. J. 1998, 335:1-13.
11. Pérez-Ramírez C., Cañadas-Garre M., Molina M.Á., Faus-Dáder M.J., Calleja-Hernández M.Á. PTEN and PI3K/AKT in non-small-cell lung cancer. Pharmacogenomics 2015, 16:1843-1862.
12. Canet-Avilés R.M., Wilson M.A., Miller D.W., Ahmad R., McLendon C., Bandyopadhyay S., Baptista M.J., Ringe D., Petsko G.A., Cookson M.R. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:9103-9108.
13. Zhang L., Shimoji M., Thomas B., Moore D.J., Yu S.W., Marupudi N.I., Torp R., Torgner I.A., Ottersen O.P., Dawson T.M., Dawson V.L. Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis. Hum. Mol. Genet. 2005, 14:2063-2073.
14. Blackinton J., Kumaran R., van der Brug M.P., Ahmad R., Olson L., Galter D., Lees A., Bandopadhyay R., Cookson M.R. Post-transcriptional regulation of mRNA associated with DJ-1 in sporadic Parkinson disease. Neurosci. Lett. 2009, 452:8-11.
15. Tatton W.G., Chalmers-Redman R., Brown D., Tatton N. Apoptosis in Parkinson's disease: signals for neuronal degradation. Ann. Neurol. 2003, 53:S61-S70.
16. Baritaud M., Boujrad H., Lorenzo H.K., Krantic S., Susin S.A. Histone H2AX: the missing link in AIF-mediated caspase-independent programmed necrosis. Cell Cycle 2010, 9:3166-3173.
17. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 1992, 55:181-184.
18. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 1967, 17:427-442.
19. Gatta L., Cardinale A., Wannenes F., Consoli C., Armani A., Molinari F., Mammi C., Stocchi F., Torti M., Rosano G.M., Fini M. Peripheral blood mononuclear cells from mild cognitive impairment patients show deregulation of Bax and Sod1 mRNAs. Neurosci. Lett. 2009, 453:36-40.
20. Kim S., Jeon B.S., Heo C., Im P.S., Ahn T.B., Seo J.H., Kim H.S., Park C.H., Choi S.H., Cho S.H., Lee W.J., Suh Y.H. Alpha-synuclein induces apoptosis by altered expression in human peripheral lymphocyte in Parkinson's disease. FASEB J. 2004, 18:1615-1617.
21. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 2000, 3:1301-1306.
22. Alam M., Schmidt W.J. Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats. Behav. Brain Res. 2002, 136:317-324.
23. Wang H., Shimoji M., Yu S.W., Dawson T.M., Dawson V.L. Apoptosis inducing factor and PARP-mediated injury in the MPTP mouse model of Parkinson's disease. Ann. N. Y. Acad. Sci. 2003, 991:132-139.
24. Chu C.T., Zhu J.H., Cao G., Signore A., Wang S., Chen J. Apoptosis inducing factor mediates caspase-independent 1-methyl-4-phenylpyridinium toxicity in dopaminergic cells. J. Neurochem. 2005, 94:1685-1695.
25. Burguillos M.A., Hajji N., Englund E., Persson A., Cenci A.M., Machado A., Cano J., Joseph B., Venero J.L. Apoptosis-inducing factor mediates dopaminergic cell death in response to LPS-induced inflammatory stimulus: evidence in Parkinson's disease patients. Neurobiol. Dis. 2011, 41:177-188.
26. Camins A., Pallas M., Silvestre J.S. Apoptotic mechanisms involved in neurodegenerative diseases: experimental and therapeutic approaches. Methods Find. Exp. Clin. Pharmacol. 2008, 30:43-65.
27. Blandini F., Sinforiani E., Pacchetti C., Samuele A., Bazzini E., Zangaglia R., Nappi G., Martignoni E. Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease. Neurology 2006, 66:529-534.